Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

Commonwealth Fusion Systems

Commonwealth Fusion Systems Raises $1.8B in Series C

Devens, MAOctober 16, 20252 min read
Employees
400+

Commonwealth Fusion Systems Raises $1.8B in Series C


Commonwealth Fusion Systems has successfully raised $1.8B in a Series C at a $4B valuation led by Tiger Global, Bill Gates, Google.


Company Overview


Commonwealth Fusion Systems is a CleanTech company headquartered in Devens, MA, founded in 2018 with 400+ employees.


Commercial fusion energy using high-temperature superconductors


Fundraising Details


  • Amount Raised: $1.8B
  • Round Type: Series C
  • Valuation: $4B
  • Date: 2025-10-16
  • Investors: Tiger Global, Bill Gates, Google

About Commonwealth Fusion Systems


Commercial fusion energy using high-temperature superconductors The company is positioned in the CleanTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Devens, MA
  • Founded: 2018
  • Team Size: 400+
  • Industry: CleanTech

What This Means


This funding round demonstrates strong investor confidence in Commonwealth Fusion Systems's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The CleanTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Commonwealth Fusion Systems's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $4B valuation marks an important milestone for Commonwealth Fusion Systems, positioning the company among notable players in the CleanTech industry.


Looking Ahead


With this new capital, Commonwealth Fusion Systems is well-positioned to execute on its growth strategy and continue building innovative solutions in the CleanTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-16. For more information about Commonwealth Fusion Systems, visit their headquarters at Devens, MA.

Company Info

Headquarters
Devens, MA
Founded
2018
Team Size
400+

Topics

Fundraising(2912)Series C(300)CleanTechCommonwealth Fusion Systems

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free